Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Postoperative Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02658318
Recruitment Status : Completed
First Posted : January 18, 2016
Last Update Posted : January 18, 2016
Sponsor:
Information provided by (Responsible Party):
Johan Abeloos, AZ Sint-Jan AV

Brief Summary:

In cleft surgery there is no current general agreement on the treatment strategy of patients with the Pierre Robin Sequence. The timing of surgery and the surgical approach depends on the treating physician or the hospital facility. Literature regarding peri- and postoperative complications in the target population are lacking.

The investigators aim to retrospectively review the charts of all cleft patients, both PRS and non-PRS, treated with an adapted Furlow palatoplasty between 01/01/2011 and 31/08/2015. The incidence of peri- and postoperative complications, with a specific focus on respiratory complications, will be examined. The value of demographic, surgical and postoperative parameters will be examined as potential risk factors for the development of complications.


Condition or disease
Pierre Robin Syndrome Cleft Palate

Layout table for study information
Study Type : Observational
Actual Enrollment : 92 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Study Start Date : January 2011
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015


Group/Cohort
Pierre Robin Syndrome (PRS)
Cleft palate patients with the Pierre Robin Syndrome.
non-PRS
Cleft palate patients without the Pierre Robin Syndrome.



Primary Outcome Measures :
  1. Incidence of peri- and postoperative complications [ Time Frame: within 4 weeks postoperative ]

Secondary Outcome Measures :
  1. Identification of potential risk factors (demographic, diagnostic, surgical) for development of postoperative complications, through regression analysis [ Time Frame: within 4 weeks postoperative ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All cleft patients consecutively treated with a modified Furlow palatoplasty between 01/01/2011 and 31/08/2015 in the Department of Oral and Maxillofacial Surgery of the General Hospital Saint-John Bruges (Bruges, Belgium) or the Department of Pediatrics of the Semmelweis University (Budapest, Hungary)
Criteria

Inclusion Criteria:

  • patients of all ages
  • patients that had undergone a modified Furlow palatoplasty
  • patients treated at the GH Saint-John Bruges (Belgium), or the cooperating Semmelweis University (Hungary)

Exclusion Criteria:

  • patients not eligible according to the abovementioned criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02658318


Locations
Layout table for location information
Belgium
General Hospital Saint-John Bruges
Bruges, Belgium
Sponsors and Collaborators
AZ Sint-Jan AV
Investigators
Layout table for investigator information
Principal Investigator: Johan Abeloos, MD Maxillofacial surgeon, Head of Department
Layout table for additonal information
Responsible Party: Johan Abeloos, Maxillofacial surgeon, Head of Department, AZ Sint-Jan AV
ClinicalTrials.gov Identifier: NCT02658318    
Other Study ID Numbers: B049201525560
First Posted: January 18, 2016    Key Record Dates
Last Update Posted: January 18, 2016
Last Verified: January 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Johan Abeloos, AZ Sint-Jan AV:
peri- and postoperative complications
airway obstruction
adapted Furlow palatoplasty
Additional relevant MeSH terms:
Layout table for MeSH terms
Cleft Palate
Pierre Robin Syndrome
Postoperative Complications
Pathologic Processes
Jaw Abnormalities
Jaw Diseases
Musculoskeletal Diseases
Maxillofacial Abnormalities
Craniofacial Abnormalities
Musculoskeletal Abnormalities
Stomatognathic Diseases
Mouth Abnormalities
Mouth Diseases
Stomatognathic System Abnormalities
Congenital Abnormalities